Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRV16 nasal lavage collection in experimentally infected healthy volunteers
NL-OMON34307Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2011
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of rhinovirus 16, sponsored by Amsterdam University Medical Center. Primary endpoints: Viral load, Infectious viral titer and 1 more. Started Nov 2011; status: active, not recruiting.
02
Drugs
rhinovirus 16
Beyond the preview
Go deeper on NL-OMON34307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34307.